Background: There has been a significant increase in overweight and obesity worldwide reaching global epidemic, with dramatic increase also among women of reproductive age or entering pregnancy. Aims of the study were to estimate the prevalence of maternal pregestational overweight and obesity and their association with and contribution to maternal obstetric complications and mode of delivery. Methods: One thousand two hundred eightysix women with singleton pregnancies were followed-up prospectively from early pregnancy to delivery in Crete. Results: The prevalence of pre-pregnancy overweight and obesity were 20 and 11.5%, respectively. After adjusting for potential confounders, overweight and/or obesity were associated with an increased risk for caesarean deliveries [RR overweight_vs._normal BMI = 1.21, 95% CI (1.06, 1.38), RR obese_vs._normal BMI = 1.21, 95% CI (1.02, 1.42)], gestational diabetes mellitus [RR obese_vs._normal BMI = 2.11, 95% CI (1.28, 3.47)] and high blood pressure [RR severy.obese_vs._normal BMI = 3.32, 95% CI (1.36, 8.06)] any time in pregnancy. Pre-pregnancy excess weight has potentially contributed to 21% of planned caesarean deliveries in primiparae (almost 45% of such cases among overweight/obese primiparea were potentially attributed to pregestational excess weight). One-third of gestational hypertension and gestational diabetes cases among overweight/obese mothers could be attributed to pregestational excess weight, although results did not reach statistical significance. Conclusions: Pregestational overweight and obesity continued to increase even more in recent years. Findings further support that maternal excess weight has a significant effect on and contribution to multiple maternal obstetric complications and the mode of delivery, underlining the necessity of obesity prevention, health policy strategies and health care that can result in significant individual and societal benefits.
Introduction
T here has been a significant increase in overweight and obesity worldwide reaching a global epidemic. 1 In Europe, one in every two adults (52%) is overweight or obese with a 10-40% increase of obesity prevalence in most European countries in the last decades. 1 The consequences of obesity and overweight are multifaceted, affecting morbidity, mortality, adding to the economic and social burden. 2 Such dramatic increase in the prevalence of overweight and obesity has also been reported in women of reproductive age and those entering a pregnancy. 3, 4 A significant increase in maternal pre-pregnancy excess weight has also been reported in Greece, with an estimated prevalence of 15.3 and 4.7% for overweight and obese women just before their pregnancy in 1998, respectively. 4 More recent data estimate that overall a 48% of Greek women over the age of 20 years are overweight or obese, 5 surmising that pregestational overweight and obesity is concurrently increasing.
Maternal obesity is associated with an increased risk of complications during pregnancy such as pre-eclampsia, gestational diabetes, gestational hypertension, increased frequency of caesarean deliveries, macrosomia, increased risk of still birth among others. 4 The aims of the present study were to estimate: (i) the prevalence of self-reported maternal pre-pregnancy overweight and obesity and their association with maternal obstetric complications and the mode of delivery, as well as, (ii) their contribution in terms of attributable fractions [population attributable fraction (PAF) and among the exposed (attributable fraction in the exposed (AFe)] to the occurrence of such outcomes.
Methods
The mother-child cohort in Crete (Rhea study)
The mother-child cohort study in Crete (Rhea study) is a prospective cohort examining a population sample of pregnant women recruited early during 1 year starting in February 2007 at the prefecture of Heraklion, Crete, Greece. 6 The first contact for recruitment was made before week 15 of gestation, at the time of the first major ultrasound examination. Women (Greek and Immigrants) were approached at the four major gynaecology and obstetrics clinics in the Heraklion prefecture, two in the public and two in the private sector, serving both rural and urban communities. During the study period, 1765 eligible women were approached, 1610 (91%) agreed to participate and 1388 (86%) were followedup until delivery. Women were then contacted multiple times during pregnancy and the postpartum period. The study was approved by the Ethical Committee of the University Hospital, Scientific Council, Heraklion, Crete, Greece, and all participants provided written, informed consent after complete description of the study.
A cohort of overall 1286 women, carrying and giving birth to a singleton, followed-up prospectively from early pregnancy to delivery with complete information on pre-pregnancy body mass index (BMI) and at least one of the outcomes of interest, was included in the present analyses.
Maternal anthropometrics and obesity classification
Height, measured at the first prenatal visit, and pre-pregnancy weight, as reported at the first major ultrasound visit, were used to calculate maternal pregestational BMI (weight in kilograms divided by the square of height in meters).
The exposure of interest was maternal pregestational overweight and obesity, categorized according to the World Health Organization recommendations. 1 In detail, the four BMI categories formed were: underweight (BMI < 18.5), normal weight (18.5 BMI < 25), overweight (25 BMI < 30) and obese (BMI ! 30). The normal-weight group was used as the reference group in data analyses. A second BMI categorization was formed, as well, with five categories, adding the category of severe obesity for a BMI of 35 kg/m 2 or greater.
Outcome variables
Information on mode of delivery categorized as planned caesarean delivery (CD), emergency CD or vaginal delivery was collected, while the mother was still in the maternity wards. Throughout the study period, screening for gestational diabetes mellitus (GDM) was performed at 24-28 week, and women were classified as having GDM at the index pregnancy if two or more of the four plasma glucose values obtained during the 100-g, 3-h oral glucose tolerance test were abnormal according to criteria proposed by Carpenter and Coustan 7 : fasting of 95 mg/dl or greater, 1 h of 80 mg/dl or greater, 2 h of 155 mg/dl or greater and 3 h of 140 mg/dl or greater.
Systolic and diastolic blood pressures were measured at the first major ultrasound visit at or before 15 weeks' gestation. Three measurements in the right arm were taken after 10 min of rest in a sitting position. The mean value obtained from the second and third readings was used in the analysis. 6 In addition, information on gestational hypertension/doctor-diagnosed pre-eclampsia (GHTNP) was obtained through computer-assisted interviews/medical records. Due to a low number of pre-eclampsia cases, no separate analysis was possible for pre-eclampsia and gestational hypertension. In addition, a variable was created 'high blood pressure, during pregnancy (any time)' to describe women who had high blood pressure any time (at least at one time point) during pregnancy {either at the 15 weeks' measurements (systolic blood pressure ! 140 mmHg and/or diastolic blood pressure ! 90 mmHg) and/or later had gestational hypertension} vs. women who never had high blood pressure during pregnancy.
Covariates
Variables with an established or potential association with overweight/obesity and/or the outcomes of interest, were used as covariates in the multivariable regression models: maternal age at delivery; maternal education (low level: 9 years of mandatory schooling, medium level: >9 years of schooling up to attending post-secondary school education but not attending university or having a technical college degree), high level: attending university or having a university/technical college degree; marital status (married/ other); ethnic origin (Greek/Other); parity (primipara / multipara); smoking during early pregnancy (smoker, quitter, nonsmoker); birth weight (bw) (in grams) and gestational age (GA, completed weeks).
Statistical analysis
Bivariate associations between categorical pre-pregnancy BMI and categorical variables were studied using Pearson's Chi-square test or Fisher's exact test (when less than five participants were expected in a cell). Bivariate associations between categorical pre-pregnancy BMI and continuous variables were studied using either one-way analysis of variance (normally distributed continuous variables) or nonparametric statistical methods (Kruskal-Wallis or Wilcoxon ranksum test) for non-normally distributed continuous variables.
Multivariable linear regression and Poisson regression models with robust error variance were fit to estimate the longitudinal associations [-coefficient with 95% Confidence Intervals (CI) and Relative Risk (RR) with 95% CI, respectively] of pre-pregnancy BMI with the outcomes of interest adjusted in all analyses for maternal age, education, origin, marital status, parity status, smoking status early in pregnancy, adding bw in the analyses for CD. Gestational diabetes and gestational hypertension were not included as potential confounders in the models assessing the effect of pre-pregnancy overweight/obesity on birth outcomes as they are considered intermediates in such association and causal pathway. 8 Analysis regarding CD was also performed focusing on women having their first child, as they are the recommended group of women where concerted efforts should be focused so as to decrease the frequency of primary caesareans. 9 Attributable fraction is the proportion by which the incidence rate would be reduced if the exposure were eliminated, 10 which can apply to the exposed (AFe) or the total population (PAF). For example, each PAF estimate is assumed to be the reduction in the proportion of disease burden that would occur in the specific population if the women in the overweight or obese groups had an outcome risk equal to that of women in the normal weight group, while nothing else (including the outcome risk in the normal group) changes. 11 It represents the outcome excess fraction in this cohort [i.e. the outcome cases that would not have happened by this specific time if exposure (overweight/obesity) had not occurred]. 12 PAFs were estimated only in the cases that pregestational maternal excess weight was a risk (and not a protective factor) for the outcome.
PAF and AFe and their CIs for each outcome were calculated using the suite 'punaf' 13 in Stata/IC version 12.1 which implements the method suggested by Greenland and Drescher. 14 In models used to estimate PAFs and AFe, women with excess weight (overweight/obese) were compared with normal weight women (reference group) in terms of their risk for each outcome event. Underweight women were not included in those models.
All hypothesis testing was conducted assuming a 0.05 significance level and a two-sided alternative hypothesis. All analyses were conducted using software STATA/IC 12.1 (StataCorp LP, College Station, TX).
Results
The prevalence of pre-pregnancy overweight and obesity in the study population was 20.3 and 11.5%, respectively. As presented in table 1, overweight and obese women were more likely to be of Greek origin (P = 0.007), married (P = 0.006), have a planned CD (P = 0.005), and also have other children (P = 0.002) compared with normal weight women. A significantly higher percent of obese women reported gestational diabetes (16.91%, P = 0.007) and had higher mean systolic (P < 0.001) and diastolic (P < 0.001) blood pressure measurements early in pregnancy.
Being overweight or obese were associated with an increased risk for caesarean deliveries in the total population [ (table 2) . If all overweight/ obese women had the same risk for CD as women of normal weight, overall 8% of all caesarean deliveries and an almost 46% of planned caesarean deliveries in primiparae could potentially be prevented (i.e. are potentially contributed to excess weight among women).
Excess maternal weight was associated with higher mean values of blood pressure early in pregnancy and obesity had an increased risk for elevated blood pressure during the pregnancy period. The risk for gestational hypertension/pre-eclampsia quadrupled in the severe obesity group compared with women of normal weight [RR = 4.11(95% CI: 1.81, 9.29)], although estimation of the increased risk was imprecise as presented by the wider CI (table 3) . Based on the blood pressure (BP) measurements, 18.5% of women had mean BP measurements in the pre-hypertensive levels in early pregnancy. Although there is no detailed information on pre-hypertension later in pregnancy, the pregestational maternal excess weight PAF for pre-hypertension early in pregnancy was 20 
Discussion
The present study indicates that pre-pregnancy prevalence of maternal overweight and obesity has increased significantly since the last reported estimation in Greece. 4 A significant association was detected between maternal pre-pregnancy excess weight and CD, which was stronger among women having their first child, as well as, with higher mean blood pressure measurements early in pregnancy. Maternal pre-pregnancy excess weight contributed significantly (in terms of attributable fractions) to the occurrence of caesarean deliveries, GDM and GHTNP.
Study findings confirmed previous reports of a positive association between maternal pregestational excess weight and an increased risk for CD compared with normal weight women.
3,4,15 The current study was able to differentiate between planned and emergency caesarean deliveries, indicating an even higher risk for planned CDs in overweight/obese women having their first child. 3 When however, we examined the contribution of overweight and obesity in terms of attributable fractions, which to the best of our knowledge has not been done previously in Greece, estimated PAFs and AFes were quite high in a country with very high CD rates, 16 as well. Several explanations have been offered for such increased risk for CDs including fetal macrosomia, inadequate monitoring of fetus and contractions, suboptimal uterine contractibility, previous CD, obstruction to the birth canal due to pelvic fat deposition or pregnancy-related complications or non-medical reasons such as the fear of litigations. 3, 4 The excess weight attributable risk for CD in the total population was a bit lower than the previous one reported by Lu et al. 17 It is of importance, however, that one-fifth of planned caesarean deliveries in women having their first child, and 46% of planned caesarean deliveries among overweight/obese primiparae could potentially be attributed to pre-pregnancy excess weight. The significance of these two estimates lies in the fact that this population of primipararous mothers has been discussed and targeted so as to achieve more appropriate CD rates of primary caesarean deliveries 9 and achieve a reduction of the current high rates of CDs worldwide.
Although not frequently used in the obstetric literature 17 PAFs are useful as they incorporate both the prevalence of a risk factor in a population (i.e. overweight/ obesity) and the estimated RR for outcome, allowing us to possibly understand better the contribution of cases by an exposure whose prevalence changes overtime even if its estimated RR remains the same. Even if the estimated RR will be decreased in the future due to increased awareness of such obstetrical outcomes and related preventive interventions, the PAFs, and thus the contributed excess cases of complications, could remain the same or even increase if the obesity epidemic is not halted. Such information could also be used to focus the attention of prevention interventions on specific predictors, not necessarily because they contribute high percentages of outcome cases, but importantly because there are effective interventions to reduce such exposure. 11 Current findings agree with previous ones on the positive association between maternal pre-pregnancy excess weight with higher blood pressure measurements, as well as, gestational hypertension. 18 In this study, only women in the severe obesity group presented with a significantly higher risk of GHTNP as compared with normal weight women, without any progressive incremental increase of this risk as BMI categories increase, as in other studies. 18, 19 However, the attributable fraction in the overweight and obese women category suggests that one-third of GHTNP cases could be attributed to excess weight.
Several biological mechanisms underlying gestational hypertensive disorders have been suggested such as an imbalance in the autonomic system, adiposity-related insulin resistance, lowchronic inflammation due to obesity and also increased systemic inflammation in the first trimester among women with excess weight and pre-eclampsia which might explain a mechanism of the association of obesity with pre-eclampsia. 18 The importance of gestational hypertension goes far beyond the time period of current pregnancy as it has been related with hypertension later in life with careful follow-up of these women suggested long after delivery. 20 However, the exact biological mechanisms remain to be clarified further.
The risk of GDM was doubled among obese women as compared with normal weight women although no significant increase in such risk was found in the overweight group. The risk for gestational diabetes increases with pre-pregnancy maternal overweight/ obesity 21 in previous reports and, in particular, it has been estimated that there is a linear increase in the risk for GDM with increasing BMI. 21 Maternal obesity is an important but also modifiable risk factor for GDM compared with other significant non-modifiable risk factors such as genetics, ethnicity or age 21 In the study population, only women in the obesity group presented with an increased risk for GDM with an overall PAF 13.4% which was lower than in previous studies. 22 However, one-third of GDM cases in mothers with pregestational excess weight could be attributed to excess weight.
The strengths of the present study include its population-based, prospective design and the detailed follow-up of women from early pregnancy to birth. The study was able to report on several outcomes in the same pregnancy and examine their association with pregestational overweight and obesity which is very helpful in understanding the multitude of effects such a predictor might have during a pregnancy and delivery. In addition, the study examined the contribution of pregestational excess weight on such outcomes in terms of attributable fractions, which are very useful as they incorporate both the prevalence of a risk factor in a population and the estimated RR for each outcome, which is not often done in the literature. Finally, the statistical models are simultaneously adjusted for important predictors of the outcomes so as to minimize uncontrolled confounding.
On the other hand, the study is not without limitations. Having in mind that pre-pregnancy weight was self-reported, as well as, reports in the literature indicating that women with higher weight might underreport their actual weight, 23 the prevalence of maternal prepregnancy overweight/obesity although quite high in the current study population, might have been underestimated in this study. We should also mention that although attributable fractions estimate the cases that would not have occurred if women were not overweight or obese (excess cases), they cannot capture the total proportion of outcome burden (i.e. maternal obstetric complications and mode of delivery) that is etiologically associated with the excess maternal pre-pregnancy weight, 11, 12 (i.e. the proportion of cases where excess weight plays an etiologic role although it does not thrust the mother from the non-case to the case-category in the time period of the current pregnancy). Such a limitation, however, does not weaken the associations and attributable fractions estimated but underlines the possibility of an even higher proportion of women, where pre-gestational weight might have contributed etiologically to events that were not detected as cases or did not have the time or other contributing factors to develop as cases, although the etiologic pathway might have been initiated with the contribution of excess weight.
In conclusion, our study further supports that pregestational maternal overweight/obesity has a detrimental effect on multiple maternal pregnancy outcomes and their contribution to such outcomes as suggested by the attributable fractions is considerable. Such morbidity during pregnancy and delivery is added to diseases for which the overweight or obese mothers are also at increased risk in the future. These, even small, effects in a larger fraction of the population-as overweight/obesity is either increasing or stabilizing in societies nowadays-result in an overall significant public health issue, which with even small gradual improvements, as with successful prevention and health policy strategies, can translate in a sizable societal, as well as, individual beneficial outcomes.
